Fund Holdings — BIOS Capital Management, LP

Total Portfolio Value
$72.58M
Total Bought
$8.58M
Total Sold
$1.70M
Net Transaction
+$6.87M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
OPUS GENETICS INC(IRD)995,2493,683,429+2,688,1809773,4624.77%+2,485
REIN THERAPEUTICS INC(RNTX)1,690,7511,690,75102,9932,3673.26%-626
COGNITION THERAPEUTICS INC(CGTX)6,000,0006,000,00002,5251,8602.56%-665
IN8BIO INC8,600,001286,664-8,313,3371,4285990.83%-828
LANTERN PHARMA INC(LTRN)1,207,7091,075,952-131,7574,2753,4004.68%-875
ACTUATE THERAPEUTICS INC9,893,6519,965,079+71,42866,98060,88783.89%-6,093
Page 1 of 1
BIOS Capital Management, LP — 13F Holdings — Q2 2025 | TickerTrail